The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
777
October 21, 1988
View Complete Issue         Table of Contents 2019 
ACE Inhibitors for Congestive Heart Failure
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
ACE Inhibitors for Congestive Heart Failure
October 21, 1988 (Issue: 777)
The angiotensin-converting enzyme (ACE) inhibitors captopril (Capoten - Squibb) and enalapril (Vasotec - Merck) are now widely used to treat chronic congestive heart failure that has not responded adequately to digitalis and diuretics (Medical...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: ACE Inhibitors for Congestive Heart Failure
Article code: 777a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.